Aptar Pharma has announced it will be a main exhibitor at CPhI Worldwide.
The event will take place in Frankfurt, Germany, from 24 October to 26 October. For many years, Aptar Pharma has had a significant presence at this major event in the pharmaceutical industry.
This year, the Aptar Pharma booth stand No. 42F10, Hall 4.2 will feature an innovation area showcasing seven healthcare technology megatrends, including a special connectivity hub, which will be dedicated to the growing field of connected healthcare solutions.
In addition to exhibiting, Aptar Pharma will present three Pharma Insight Briefings that will highlight its latest innovations and developments in the following drug delivery system areas:
Innovative respiratory solutions for expanding your product portfolio
Director of business development at Aptar Pharma Guenter Nadler will deliver an insightful talk on innovative respiratory solutions on the first day of CPhI Worldwide. As a global rise in allergies and air pollution have led to a significant increase in upper respiratory tract diseases, typical over-the-counter medications and household remedies cannot always fulfil the needs of today’s on-the-go lifestyle.
As one of the leading drug delivery system providers for the development of dispensing solutions for pharmaceutical cough and cold applications, Aptar Pharma’s proven nasal spray and bag on valve systems have become the treatment standard in the industry. During the talk, attendees will learn more about how these systems meet today’s requirements for compliant patient treatment.
Guenter Nadler’s pharma insight briefing will take place on Tuesday, 24 October at 10:30 at the Innopack Zone, G1A3.
Driving better patient outcomes with connectivity
Director of business development for connected devices Sai Shankar will present Aptar Pharma’s second pharma insight briefing at CPhI Worldwide.
Using a patient-centric design approach, Aptar Pharma supports pharmaceutical companies worldwide with custom-made solutions, including connected technologies for the treatment of respiratory diseases such as asthma and COPD.
The findings of a study recently conducted by Aptar Pharma on its integrated connected pressurised metered-dose inhaler (pMDI) and connected health devices portfolio will be among the topics presented at this briefing.
Sai Shankar’s pharma insight briefing will take place on Tuesday, 24 October at 15:50 at the Innopack Zone, G1A3.
Setting new standards for coated stoppers
Senior business project manager for injectables at Aptar Pharma Arnaud Fournier will exclusively introduce PremiumCoat™, a coated stopper that represents a step-change in the provision of elastomeric stoppers with a market leading reduction in particulates. This technology is Aptar Pharma’s response to the growing challenges of developing more sensitive drugs in the pharmaceutical market.
Arnaud Fournier’s pharma insight briefing on the latest development in Aptar Pharma’s premium injectables portfolio will take place on Wednesday, 25 October at 10:30 at the Innopack Zone, G1A3.
With more than 42,000 pharmaceutical professionals attending CPhI Worldwide every year, Aptar Pharma welcomes the opportunity to meet with its valued customers and business partners. It will exchange with key opinion leaders in the pharmaceutical industry and showcase its latest key innovations.
Join Aptar Pharma at booth No. 42F10, Hall 4.2, where its team of experts will be pleased to give an overview of their wide product portfolio that provides innovative drug delivery systems, components and services covering a broad range of delivery routes.